Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.95 | 0.13 | 623.06 |
| EPS, GAAP | 0.91 | 0.08 | 0.08 |
| Consensus Estimate | 1.17 | 1.10 | 6.36 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 4.18 | 4.12 | 1.53 |
| EPS, GAAP | 3.86 | 3.49 | 10.72 |
| Consensus Estimate | 5.13 | 4.97 | 3.22 |
| JNJ | Industry Average | |
| P/E (TTM) | 20.77 | NA |
| P/E (Forward) | 15.26 | NA |
| PEG Ratio | 2.48 | 2.20 |
| Price/Sales | 3.37 | 18.91 |
| Beta | 0.53 | 0.70 |
| 4:49 PM | 4/4/2013 | UPDATE: U.S. Appeals Court Reverses $593 Million Award Against J&J |
| 4:44 PM | 4/4/2013 | Appeals Court Reverses $593 Million Award Against J&J |
| 4/4/2013 | Court Reverses Award Against J&J (WSJ.com) |
| 4/4/2013 | How Much DJIA Dividends Will Get Raised in April (XOM, CVX, IBM, JNJ, DOW, DD, CSCO, MSFT, GE) (24/7 Wall St) |
| 4/3/2013 | Drug Firms Expand Powers to Recoup Pay (WSJ.com) |
| 3/31/2013 | Not Far From the Tree: Apples Lead Japan Scientists to New Drug (WSJ.com) |
| 4/2/2013 | Investing, the Rudyard Kipling Way (Barrons.com) |
| 3/29/2013 | FDA Approves J&J's New Diabetes Drug (WSJ.com) |
| 3/28/2013 | Five Big Dividend Hikes to Watch for in April (XOM, CVX, JNJ, DOW, IBM) (24/7 Wall St) |
| 3/22/2013 | Low-Quality Stocks Have Zoomed. Time to Shift Gears? (WSJ.com) |
